Effect of proinflammatory cytokines (IL-6, TNF-α, IL-1β) on hemodynamic performance during orthotopic liver transplantation

[1]  S. Calvano,et al.  Inflammatory cytokines and cell response in surgery. , 2000, Surgery.

[2]  S. Lowry,et al.  Inflammatory cytokines in major surgery: a functional perspective , 1999, Intensive Care Medicine.

[3]  P. Clavien,et al.  Interleukin‐6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent , 1997, Hepatology.

[4]  S. D. Lee,et al.  Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation. , 1996, Scandinavian journal of gastroenterology.

[5]  S. Ito,et al.  Interleukin 1 β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells , 1996, Hepatology.

[6]  D. Laskin,et al.  Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression , 1995, Hepatology.

[7]  K. Frei,et al.  Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes. , 1995, European journal of biochemistry.

[8]  R. Groszmann,et al.  Tumor necrosis factor α: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats , 1995 .

[9]  T. Starzl,et al.  Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. , 1994, Transplantation.

[10]  S. Friedman,et al.  Parenchymal and Nonparenchymal Cell Interactions in the Liver , 1993, Seminars in liver disease.

[11]  P. Pizcueta,et al.  Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. , 1992, Gastroenterology.

[12]  R. Groszmann,et al.  The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats , 1992, Hepatology.

[13]  D. Kwiatkowski,et al.  Systemic cytokine response after major surgery , 1992, The British journal of surgery.

[14]  W. Fraser,et al.  Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. , 1990, Clinical science.

[15]  S. Sherlock,et al.  Vasodilatation associated with hepatocellular disease: relation to functional organ failure. , 1990, Gut.

[16]  T. Starzl,et al.  ENDOTOXAEMIA, PULMONARY COMPLICATIONS, AND THROMBOCYTOPENIA IN LIVER TRANSPLANTATION , 1989, The Lancet.

[17]  J. Bruix,et al.  Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. , 1985, Gastroenterology.

[18]  R. Groszmann,et al.  Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis , 1999, American Journal of Gastroenterology.

[19]  S. Heptinstall,et al.  RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION , 1988, The Lancet.